The Pharma Data

JANUARY 9, 2021

CDMO Services assumes continued growth in Development Services (DVS), Drug Substance (DS) manufacturing, and Drug Product (DP) manufacturing and Packaging for both clinical- and commercial-stage projects on behalf of a growing list of pharmaceutical and biotechnology innovators and government/NGO customers. FOOTNOTES. (1)

Government 40

Government Vaccine Production Licensing 40

FDA Law Blog: Biosimilars

JULY 10, 2025

On June 22, 2025, Texas Governor Greg Abbott signed into law SB 25 —nicknamed the “Make Texas Healthy Again” law—requiring, among other things, that any food or beverage containing one of 44 specified “ingredients” must carry a prominent warning label if FDA “requires the ingredient to be named on a food label.” Synthetic dyes.

Packaging 66

Packaging Regulations FDA Production 66

New Drug Approvals

APRIL 27, 2025

3] Flurpiridaz ( 18 F) was approved for medical use in the United States in September 2024. [3] 3] Flurpiridaz ( 18 F) was approved for medical use in the United States in September 2024. [3] Jump up to: a b c d e f g h i j k “FDA approves imaging drug for evaluation of myocardial ischemia” U.S. 2020.05.063.

FDA 57

FDA Clinical Trials FDA Approval Disease 57